Clearance of the intracellular high level of the Tau protein directed by an artificial synthetic hydrolase
Tingting Chu, Qianqian Li, Tian Qiu, Zhanyi Sun, Zhiwen Hu, Yong‐Xiang Chen, Yufen Zhao, Yanmei Li
Abstract
Tingting Chu, Qianqian Li, Tian Qiu, Zhanyi Sun, Zhiwen Hu, Yong‐Xiang Chen, Yufen Zhao, Yanmei Li
Abstract
Promoting clearance of intracellular excessive tau is a potential therapeutic strategy for treating Alzheimer's disease. In this work, we designed and synthesized a cyclen-hybrid artificial 'hydrolase' I1-Cu(II) to cleave tau in vitro. Furthermore, a cell-permeable 'hydrolase' I2-Cu(II), derived from I1-Cu(II), was also synthesized to cleave intracellular tau proteins.
OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Promoting clearance of intracellular excessive tau is a potential therapeutic strategy for treating Alzheimer's disease. In this work, we designed and synthesized a cyclen-hybrid artificial 'hydrolase' I1-Cu(II) to cleave tau in vitro. Furthermore, a cell-permeable 'hydrolase' I2-Cu(II), derived from I1-Cu(II), was also synthesized to cleave intracellular tau proteins.
Key concepts: Intracellular, Hydrolase, Cleave, In vitro, Cyclen, Chemistry, Biochemistry, Enzyme